Divya Sharma | Pharmacology | Research Excellence Award

Published on by Young Scientists Awards

Research Excellence Award

Divya Sharma
Vellore Institute of Technology, India
Divya Sharma
Affiliation Vellore Institute of Technology
Country India
Scopus ID 59553841100
Documents 4
Citations 8
h-index 2
Subject Area Pharmacology
Event International Young Scientists Award
ORCID 0009-0004-3376-0847

Divya Sharma is a researcher associated with Vellore Institute of Technology, India, with academic interests in pharmacology and related biomedical sciences. Her research profile reflects engagement in scientific studies addressing pharmaceutical sciences, therapeutic investigations, and interdisciplinary health-related research. Through scholarly publications and indexed research contributions, Sharma has participated in the advancement of scientific understanding within pharmacological and healthcare-oriented domains.[1]

Abstract

This article summarizes the academic profile and scholarly activities of Divya Sharma in the field of pharmacology. Her research contributions include publication-based investigations and interdisciplinary studies associated with pharmaceutical sciences and biomedical research. The profile highlights publication metrics, citation indicators, and academic participation relevant to contemporary scientific research practices.[2]

Keywords

  • Pharmacology
  • Biomedical Research
  • Pharmaceutical Sciences
  • Healthcare Research
  • Scientific Publications

Introduction

Pharmacology research contributes significantly to healthcare innovation and therapeutic development through scientific experimentation and evidence-based investigations. Researchers in this field support advancements in drug discovery, treatment evaluation, and biomedical understanding. Divya Sharma’s scholarly profile reflects participation in research activities connected with pharmaceutical sciences and scientific communication through academic publishing platforms.[3]

Research Profile

Divya Sharma is affiliated with Vellore Institute of Technology, India. Her documented academic metrics include four research documents, eight citations, and an h-index of two. Her academic work is primarily associated with pharmacology and interdisciplinary biomedical studies involving healthcare-related scientific investigations.[1]

Research Contributions

  • Participation in pharmacological and biomedical research studies.
  • Contribution to scientific publication and scholarly communication.
  • Research involvement in healthcare-oriented scientific investigations.
  • Engagement in interdisciplinary pharmaceutical science research initiatives.

Publications

The publication profile of Divya Sharma includes indexed scholarly articles associated with pharmacology and healthcare sciences. Her research output demonstrates participation in academic dissemination through recognized scholarly platforms and scientific databases. Citation indicators further reflect the visibility and accessibility of her published work within academic communities.[2]

Research Impact

The research impact associated with Sharma’s academic work is reflected through citation activity, publication records, and scholarly indexing metrics. Her work contributes to broader scientific discussions concerning pharmacological investigations and biomedical applications. The documented citation profile and research participation indicate continuing academic engagement in scientific research activities.

Award Suitability

Based on the available academic profile and research documentation, Divya Sharma demonstrates qualifications relevant to recognition under the International Young Scientists Award program. Her scholarly activities, research publications, and participation in pharmacology-focused scientific studies align with the objectives commonly associated with research excellence and young scientist recognition initiatives.[6]

Conclusion

Divya Sharma academic profile illustrates active participation in pharmacology and biomedical research through publications, citation-based contributions, and scholarly engagement. Her work reflects continuing involvement in scientific communication and healthcare-related investigations. The profile presented in this article provides a concise overview of her academic achievements and research-oriented contributions.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Divya Sharma, Author ID 59553841100. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59553841100
  2. Google Scholar. (n.d.). Publication and citation profile of Divya Sharma.
    https://scholar.google.com/citations?hl=en&user=VsCMB4QAAAAJ&view_op=list_works&authuser=1&gmla=AIqSsVuOD0ny7xiZ4GIdOG3Ysew9JTNbTucp0boEKBLSh7lhzv6rBFfsUcdfByyt0h1ZOtsgMYoS-wb1Sn3EVEao
  3. Orcid. (n.d.). Orcid author details: Divya Sharma, Author ID 0009-0004-3376-0847.
    https://orcid.org/0009-0004-3376-0847
  4. International Young Scientists Award. (n.d.). Award program and academic recognition criteria.
    https://youngscientistawards.com/

Akash Vikal | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Young Scientist Award

Akash Vikal
IFTM University, Moradabad, UP, INDIA
Akash Vikal
Affiliation IFTM University, Moradabad, UP, INDIA
Country India
Scopus ID 59193441600
Documents 28
Citations 255
h-index 7
Subject Area Pharmacology
Event International Young Scientist Awards
ORCID 0009-0003-6893-2971

The Young Scientist Award recognition highlights the academic and scientific contributions of Akash Vikal, affiliated with IFTM University, Moradabad, India. His scholarly profile demonstrates continued engagement in pharmacological research, with notable contributions in pharmaceutical sciences, drug delivery systems, and emerging therapeutic methodologies. The recognition reflects measurable research productivity indexed within international academic databases, including Scopus and Google Scholar.[1]

Abstract

Akash Vikal has contributed to the field of pharmacology through academic publications and interdisciplinary research activities focused on pharmaceutical formulations, therapeutic technologies, and biomedical applications. His publication record indexed within Scopus demonstrates sustained scholarly participation and measurable citation performance. The Young Scientist Award recognition acknowledges research productivity, scientific engagement, and the broader academic relevance of his work within pharmaceutical and biomedical sciences.[2]

Keywords

Pharmacology, Pharmaceutical Sciences, Drug Delivery Systems, Biomedical Research, Therapeutics, Nanomedicine, Academic Research, Scopus Publications, Citation Impact, Young Scientist Award

Introduction

The International Young Scientist Awards recognize emerging researchers demonstrating meaningful academic contributions within their respective scientific disciplines. Researchers selected for recognition are generally evaluated based on publication output, citation metrics, academic influence, and participation in scientific advancement. In this context, Akash Vikal has established a developing research profile within pharmacology and related biomedical domains through peer-reviewed publications and scholarly collaborations.[3]

Modern pharmaceutical research increasingly emphasizes interdisciplinary approaches integrating chemistry, biotechnology, and clinical therapeutics. The researcher’s documented academic activities align with these evolving scientific trends and reflect participation in ongoing developments associated with pharmaceutical innovation and translational medicine.[4]

Research Profile

Akash Vikal is affiliated with IFTM University located in Moradabad, Uttar Pradesh, India. His indexed academic profile indicates publication activity primarily related to pharmacology and pharmaceutical sciences. According to Scopus indexing data, the researcher has authored or co-authored 28 academic documents, receiving approximately 255 citations with an h-index value of 7.[1]

  • Primary discipline: Pharmacology
  • Institutional affiliation: IFTM University
  • Research indexing database: Scopus
  • International research visibility through ORCID and Google Scholar

Research Contributions

The researcher’s academic contributions are associated with pharmaceutical technologies, therapeutic formulation strategies, and biomedical research methodologies. Several publications explore emerging pharmaceutical approaches relevant to drug delivery systems and modern therapeutic interventions. Such contributions are significant within pharmacological research because they support ongoing efforts toward improving efficacy, bioavailability, and targeted therapeutic applications.[5]

Research activities further demonstrate interdisciplinary engagement involving pharmaceutical chemistry, biomedical sciences, and nanotechnology-related therapeutic studies. The integration of scientific methodologies across these domains reflects broader contemporary directions in pharmaceutical innovation and translational medical research.[6]

  • Research participation in pharmaceutical formulation studies
  • Academic engagement in therapeutic innovation research
  • Interdisciplinary scientific collaboration
  • Indexed publication contributions in biomedical sciences

Publications

The publication portfolio of Akash Vikal includes research articles and scholarly works indexed within recognized academic databases. Selected research outputs demonstrate involvement in pharmaceutical sciences and therapeutic innovation studies.[2]

  1. Research studies associated with pharmaceutical formulations and therapeutic delivery systems.
  2. Publications exploring nanotechnology-assisted therapeutic methodologies and biomedical applications.
  3. Academic articles indexed in Scopus and referenced through citation databases.

Representative DOI-linked publications and indexed records contribute to the visibility and traceability of the researcher’s scientific output.[7]

Research Impact

Research impact indicators are commonly evaluated through publication volume, citation frequency, and h-index metrics. Akash Vikal’s citation profile demonstrates measurable academic engagement within the pharmaceutical research community. Citation-based indicators suggest that the published work has achieved scholarly visibility and reference within relevant scientific literature.[1]

Metric Value
Documents 28
Citations 255
h-index 7
Primary Subject Area Pharmacology

Award Suitability

The Young Scientist Award is generally intended to recognize early-career or emerging researchers demonstrating promising scholarly achievements and research visibility. Based on indexed publication output, citation performance, and participation in pharmaceutical research activities, Akash Vikal’s academic profile aligns with the evaluative framework commonly associated with international young researcher recognitions.[3]

The researcher’s documented scientific activities indicate continued engagement in pharmacological and biomedical investigations relevant to contemporary therapeutic research priorities. Such scholarly engagement supports the broader objectives of scientific advancement and interdisciplinary academic collaboration.[6]

Conclusion

Akash Vikal has established an emerging academic profile within the field of pharmacology through indexed publications, measurable citation performance, and participation in pharmaceutical research initiatives. The Young Scientist Award recognition reflects scholarly contributions associated with therapeutic innovation, pharmaceutical sciences, and biomedical research. Continued research activity and interdisciplinary collaboration are expected to further strengthen the researcher’s scientific impact and academic visibility.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Akash Vikal, Author ID 59193441600. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=59193441600
  2. Google Scholar. (n.d.). Academic citation profile of Akash Vikal.
    https://scholar.google.com/citations?user=DmTcek4AAAAJ&hl=en&oi=sra
  3. International Young Scientist Awards. (n.d.). Award evaluation and recognition criteria.
    https://youngscientistawards.com/
  4. Allen, T. M., & Cullis, P. R. (2013). Liposomal drug delivery systems: From concept to clinical applications.DOI: https://doi.org/10.1016/S0140-6736(13)61809-7
  5. Patra, J. K., et al. (2018). Nano based drug delivery systems: Recent developments and future prospects.DOI: https://doi.org/10.1016/j.jconrel.2018.10.015
  6. Peer, D., et al. (2007). Nanocarriers as an emerging platform for cancer therapy.DOI: https://doi.org/10.1038/nnano.2007.387
  7. Torchilin, V. P. (2014). Multifunctional nanocarriers.DOI: https://doi.org/10.1038/nrd.2014.73

Lakshmanan Govindan | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Lakshmanan Govindan | Pharmacology | Young Scientist Award

Sri Lakshmi Narayana Institute of Medical Sciences | India

Dr Lakshmanan Govindan is a dedicated researcher in Botany with expertise in medicinal plant studies and bioactive compound analysis. His research focuses on isolating and characterizing natural compounds with anticancer, antidiabetic, and antimicrobial potential. He has contributed extensively to scientific literature, including research articles, patents, and book chapters in the fields of biotechnology and phytochemistry. His work also explores green synthesis of nanoparticles and their biomedical applications. He actively engages in academic evaluation, research reviewing, and interdisciplinary scientific advancements. His scholarly impact is reflected in 575 citations across 574 documents, with 28 published works and an h-index of 7, demonstrating consistent contributions and recognition in his field.

Citation Metrics (Scopus)

600500

400

300

200

100

0

Citations
575

Documents
28

h-index
7

 


View Scopus Profile
 View Orcid Profile
 View Google Scholar Profile

Featured Publications

 

Ravi Prakash Degala | Pharmacology | Young Researcher Award

Published on by Young Scientists Awards

Dr. Ravi Prakash Degala | Pharmacology | Young Researcher Award

Pydah College of Pharmacy | India

Dr. Ravi Prakash Degala is a pharmaceutical researcher specializing in clinical research, pharmacotherapy, and pharmacovigilance with a focus on improving patient outcomes and drug safety. His research spans diverse areas including disease management, adverse drug reactions, oncology, cardiology, and evidence-based pharmacy practice. He has contributed over 35 research publications, along with patents, book chapters, and edited academic books, reflecting strong scholarly productivity. His research profile includes 145 citations, an h-index of 3, and an i10-index of 1, indicating steady academic impact. He is actively engaged in advancing pharmaceutical sciences through research, innovation, and academic contributions.


View Google Scholar Profile

Featured Publications

Dharmalingam Kirubakaran | Pharmacology | Young Scientist Award

Published on by Young Scientists Awards

Dr. Dharmalingam Kirubakaran l Pharmacology
| Young Scientist Award

Saveetha University | India

Dr. Dharmalingam Kirubakaran’s research focuses on the green synthesis of nanoparticles and their multifaceted biomedical applications, encompassing antioxidant, antibacterial, anti-inflammatory, antidiabetic, and anticancer activities. His work extensively explores plant-mediated nanoparticle synthesis using bioactive extracts from species such as Strobilanthes cordifolia, Acmella caulirhiza, Cajanus albicans, Lantana camara, and Mangifera indica, combining traditional phytochemistry with advanced nanotechnology approaches. Characterization techniques employed include UV-Visible spectrophotometry, Fourier Transform Infrared (FTIR) spectroscopy, X-ray Diffraction (XRD), Scanning and Transmission Electron Microscopy (SEM/TEM), Energy Dispersive Spectroscopy (EDAX), and Dynamic Light Scattering (DLS), ensuring comprehensive analysis of particle morphology, size, and stability. Complementing synthesis studies, his in vitro assessments encompass antibacterial activity against Gram-positive and Gram-negative bacteria, antioxidant assays such as DPPH, ABTS, H₂O₂, and FRAP, anti-inflammatory and antidiabetic evaluations, anticholinergic enzyme inhibition, and anticancer effects on multiple cell lines including MCF-7, A431, HeLa, and A549. Additional investigations include mosquito larvicidal bioassays, photocatalytic dye degradation, and ethnobotanical studies of medicinal plants. His publications reveal a strong emphasis on sustainable, plant-based nanomaterials for biomedical applications, with work on PVA–PEG and chitosan-based nanocomposites highlighting potential in food packaging, therapeutic interventions, and drug delivery. Collectively, his research integrates phytochemistry, nanotechnology, and pharmacological evaluation to advance environmentally friendly and biologically effective solutions for healthcare and environmental challenges.

Featured Publications

  • Kirubakaran, D., Wahid, J. B. A., Karmegam, N., Jeevika, R., Sellapillai, L., … (2025). A comprehensive review on the green synthesis of nanoparticles: Advancements in biomedical and environmental applications. Biomedical Materials & Devices, 1–26.

  • Manimegalai, P., Selvam, K., Loganathan, S., Kirubakaran, D., Shivakumar, M. S., … (2024). Green synthesis of zinc oxide (ZnO) nanoparticles using aqueous leaf extract of Hardwickia binata: Their characterizations and biological applications. Biomass Conversion and Biorefinery, 14(11), 12559–12574.

  • Kirubakaran, D., Selvam, K., Prakash, P., Shivakumar, M. S., Rajkumar, M. (2023). In-vitro antioxidant, antidiabetic, anticholinergic activity of iron/copper nanoparticles synthesized using Strobilanthes cordifolia leaf extract. OpenNano, 14, 100188.

  • Rajkumar, M., Presley, S. I. D., Govindaraj, P., Kirubakaran, D., Farahim, F., Ali, T., … (2025). Synthesis of chitosan/PVA/copper oxide nanocomposite using Anacardium occidentale extract and evaluating its antioxidant, antibacterial, anti-inflammatory and … Scientific Reports, 15(1), 3931.

  • Kirubakaran, D., Bupesh, G., Wahid, J. B. A., Murugeswaran, R., Ramalingam, J., … (2025). Green synthesis of zinc oxide nanoparticles using Acmella caulirhiza leaf extract: Characterization and assessment of antibacterial, antioxidant, anti … Biomedical Materials & Devices, 1–22.

Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Published on by Young Scientists Awards

Prof. Faisal Al-Akayleh | Pharmacology | Excellence in Innovation

Professor Faisal Al-Akayleh, an editorial board member of the Jordan Journal of Pharmaceutical Sciences.  university of Petra, Jordan

🌟 Professor Faisal T. Al-Akayleh, Ph.D. is a distinguished expert in pharmaceutics and pharmaceutical technology, serving as the Head of the Department of Pharmaceutics and Pharmaceutical Technology at the University of Petra, Amman, Jordan. With a robust academic and professional background, Professor Al-Akayleh has made remarkable contributions as a pharmaceutical researcher, inventor, and consultant. He has authored five patents in the fields of nanotechnology, pharmaceutical science, and environmental applications. His innovative spirit is reflected in his leadership roles and impactful projects in drug delivery and nanotechnology. 💊🔬

Publication Profile

Education

🎓 Ph.D. in Pharmaceutics and Pharmaceutical Technology – Professor Al-Akayleh’s academic journey is marked by his expertise in pharmaceutics, enabling him to advance the pharmaceutical industry with groundbreaking innovations. His education laid the foundation for his significant contributions to pharmaceutical technology and material science. 📚

Experience

📈 With years of experience in academia and the pharmaceutical industry, Professor Al-Akayleh has served as a technical manager and consultant for various pharmaceutical companies. As an associate professor, he has led groundbreaking research projects and collaborated on numerous industry-funded initiatives. His leadership extends to his roles as a board member of the Jordan Journal of Pharmaceutical Sciences and the University of Petra Pharmaceutical Center. He also chairs the Ethical Approval Committee at the University of Petra. 🧪

Awards and Honors

🏆 Professor Al-Akayleh received the prestigious El Hassan Bin Talal Award for Scientific Excellence (2018) for his collaborative project on developing an oral insulin delivery system. His dedication to innovation has garnered recognition for advancing pharmaceutical research and development. ✨

Research Focus

🔍 Professor Al-Akayleh specializes in drug delivery systems, nanotechnology, pharmaceutical material science, and environmental sustainability. His research addresses critical challenges in developing innovative drug formulations, including nanoparticles for improved skin permeation and novel excipients for enhanced drug delivery. 🌐

Conclusion

Professor Faisal T. Al-Akayleh is a trailblazer in pharmaceutical sciences, combining academic excellence with industrial expertise to deliver innovative solutions. His commitment to advancing pharmaceutics and nanotechnology continues to inspire scientific progress and foster meaningful collaborations. 🌟

Publications

Recent Advances in Ocular Drug Delivery: Insights into Lyotropic Liquid Crystals (2024)
Published in Pharmaceuticals, cited by 10 articles.

Novel therapeutic deep eutectic system for the enhancement of ketoconazole antifungal activity and transdermal permeability (2024)
Published in Journal of Molecular Liquids, cited by 15 articles.

AI-Driven Physical Rehabilitation Strategies in Post-Cancer Care (2024)
Presented at IEEE ICCR 2024 Conference, cited by 5 articles.

What We Know About the Actual Role of Traditional Probiotics in Health and Disease (2024)
Published in Probiotics and Antimicrobial Proteins, cited by 12 articles.

Utilizing olive leaves biomass as an efficient adsorbent for ciprofloxacin removal (2024)
Published in Environmental Monitoring and Assessment, cited by 8 articles.

Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

Published on by Young Scientists Awards

Mr.Surapon Nochaiwong | Pharmacoepidemiology | Best Researcher Award

 

👨‍🏫 🌾🌟Mr. Surapon Nochaiwong, a distinguished figure in pharmacoepidemiology and clinical epidemiology, serves as an academic staff member in the Department of Pharmaceutical Care at Chiang Mai University, Thailand. 🎓 Holding a Doctor of Pharmacy (Pharm.D.) degree, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at the Faculty of Pharmacy.Nochaiwong’s educational journey includes a Pharm.D. from Chiang Mai University, a General Residency in Pharmacotherapy, and diplomas in Clinical Statistics and Clinical Epidemiology. His commitment to education and research makes him a respected figure in the academic and scientific community. 🔬🎓

 

🌐 Professional Profiles

Affiliation/Community 🏛️

Pharmacoepidemiology and Statistics Research Center (PESRC) Faculty of Pharmacy, Chiang Mai University 50200 Department of Pharmaceutical Care Faculty of Pharmacy, Chiang Mai University 50200

Personal Statement 🌟

Surapon Nochaiwong earned his Doctor of Pharmacy (Pharm.D.) degree from Chiang Mai University, Thailand. Currently holding an academic position in the Department of Pharmaceutical Care, Faculty of Pharmacy, he is also the founding Vice Head of the Pharmacoepidemiology and Statistics Research Center (PESRC) at Chiang Mai University.

Since joining the Faculty of Pharmacy in 2012, Nochaiwong has actively contributed as a young scientist and principal investigator on over 10 extramurally funded local and national grants. He has an impressive publication record with more than 50 manuscripts and conference abstracts, accumulating over 800 citations in the international scientific community. His research interests span clinical epidemiology, pharmacoepidemiology, patient-reported outcomes in dialysis patients, and systematic review & evidence-based synthesis in nephrology and dermatology.

Areas of Expertise/Knowledge 🧠

Clinical Epidemiology, Pharmacoepidemiology, Dialysis, Chronic Pruritus, Patient-Reported Outcomes, Systematic Review and Knowledge Synthesis, Mental Health and COVID-19

Positions and Honors 🏆

2021 – Present: Co-principal investigator, Government of Canada, the Canadian Institutes of Health Research (CIHR) Operating Grant: Emerging COVID-19 Research Gaps & Priorities, 2020 – Present: Principal investigator and head of the HOME-COVID-19 consortium, 2016 – Present: Head of the Pharmacoepidemiology and Statistics Research Center (PESRC), 2017 – Present: Head of the Thai Renal Outcomes Research (THOR) Investigators, 2019 – Present: Vice head of the Evidence-Based Synthesis in Dermatology (EBSD), 2015 – 2017: Co-principal investigator, Funded by Health Systems Research Institute of Thailand (HSRI) through National Research Council of Thailand (NRCT), 2013 – 2014: Principal investigator, Young Researcher Granted by Chiang Mai University

Education 📚

Doctor of Pharmacy (Pharm.D.), Faculty of Pharmacy, Chiang Mai University, Thailand, General Residency in Pharmacotherapy, The College of Pharmacotherapy of Thailand, Thailand,  Diploma in Clinical Statistics, Faculty of Medicine, Chiang Mai University, Thailand Diploma in Clinical Epidemiology, Faculty of Medicine, Chiang Mai University, Thailand

Work Experience 👨‍💼

2012-Present: Faculty of Pharmacy, Chiang Mai University, Thailand This detailed information provides a comprehensive overview of Surapon Nochaiwong’s academic and research journey, along with his significant contributions and affiliations in the field of pharmacy and healthcare.

📚Top Noted Publication

Comparative Safety Profiles of Individual Second-Generation H1-Antihistamines for the Treatment of Chronic Urticaria: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials

Clinical Outcomes, Patient-Reported Outcomes, and Economic Burden for Thai People Living with Chronic Urticaria (CORE-CU) in routine practice: A study protocol for a monocentric prospective longitudinal study

Transcultural adaptation and psychometric validation of the Thai-Brief Resilient Coping Scale: a cross-sectional study during the coronavirus disease 2019 pandemic in Thailand

Service-level barriers to and facilitators of access to services for the treatment of alcohol use disorder and problematic alcohol use: protocol for a scoping review

Psychological Resilience and Adverse Mental Health Issues in the Thai Population during the Coronavirus Disease 2019 Pandemic

Evidence Gaps in Clinical Trials of Pharmacologic Treatment for H1-Antihistamine-Refractory Chronic Spontaneous Urticaria: A Systematic Review and Future Perspectives

Pharmacological interventions for hidradenitis suppurativa: a protocol for systematic review and network meta-analysis of randomised trials and non-randomised studies

Costs of Next-Generation Sequencing Assays in Non-Small Cell Lung Cancer: A Micro-Costing Study

Disparities and Factors Associated with Coronavirus Disease-2019-Related Public Stigma: A Cross-Sectional Study in Thailand

Use of Thiazide Diuretics and Risk of All Types of Skin Cancers: An Updated Systematic Review and Meta-Analysis